Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.
作者信息
Yuwanati Monal, Sarode Sachin C, Sarode Gargi S, Gadbail Amol, Gondivkar Shailesh
机构信息
Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, India.
Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Maharashtra State, Pune, India.
出版信息
Oral Oncol. 2022 Nov;134:106120. doi: 10.1016/j.oraloncology.2022.106120. Epub 2022 Sep 12.
Abstract
摘要
相似文献
1
Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.端粒酶逆转录酶突变：口腔鳞状细胞癌及其癌前病变的风险预测指标和药物靶点。
Oral Oncol. 2022 Nov;134:106120. doi: 10.1016/j.oraloncology.2022.106120. Epub 2022 Sep 12.
2
TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.端粒酶逆转录酶（TERT）启动子热点突变在印度宫颈癌和口腔鳞状细胞癌中很常见。
Tumour Biol. 2016 Jun;37(6):7907-13. doi: 10.1007/s13277-015-4694-2. Epub 2015 Dec 23.
3
Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition.端粒酶逆转录酶可能通过诱导上皮-间质转化促进口腔鳞状细胞癌的进展。
Int J Oncol. 2015 May;46(5):2205-15. doi: 10.3892/ijo.2015.2927. Epub 2015 Mar 13.
4
Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.人端粒酶RNA组分（hTERC）扩增：口腔潜在恶性病变的恶性遗传标志物。
Hum Pathol. 2015 Sep;46(9):1275-81. doi: 10.1016/j.humpath.2015.05.013. Epub 2015 May 30.
5
TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.TERT 启动子突变阳性口腔癌，头颈鳞状细胞癌中具有临床和遗传特征的亚群。
Head Neck. 2023 Dec;45(12):3107-3118. doi: 10.1002/hed.27540. Epub 2023 Oct 10.
6
Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.人端粒酶逆转录酶是鳞状细胞癌中癌症抑制的一个有前景的靶点。
Anticancer Res. 2014 Nov;34(11):6389-95.
7
The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.人端粒酶逆转录酶的甲基化状态和表达在口腔癌发生过程中显著升高。
APMIS. 2017 Sep;125(9):797-807. doi: 10.1111/apm.12723. Epub 2017 Aug 2.
8
Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.关于循环微小RNA作为口腔潜在恶性疾病和口腔鳞状细胞癌治疗分子的评论。
Oral Oncol. 2022 Jul;130:105901. doi: 10.1016/j.oraloncology.2022.105901. Epub 2022 May 6.
9
MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.微小RNA-138及其靶点：一种用于口腔鳞状细胞癌的治疗分子。
Oral Oncol. 2022 Jul;130:105925. doi: 10.1016/j.oraloncology.2022.105925. Epub 2022 May 21.
10
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma.基于唾液mRNA的生物标志物在预测口腔鳞状细胞癌中的潜在应用。
Oral Oncol. 2022 Dec;135:106215. doi: 10.1016/j.oraloncology.2022.106215. Epub 2022 Oct 20.
引用本文的文献
1
Association of TERT promoter mutation with oral squamous cell carcinoma: a systematic review and meta-analysis.端粒酶逆转录酶（TERT）启动子突变与口腔鳞状细胞癌的关联：一项系统评价和荟萃分析
Sci Rep. 2025 Apr 30;15(1):15257. doi: 10.1038/s41598-025-98133-6.
Zotero 插件